RHD deletion in a patient with chronic myeloid leukemia
By:
Paid access
|Mar 2020Authors
A. Murdock
Good Samaritan Hospital Medical Center, West Islip, NY
D. Assip
Good Samaritan Hospital Medical Center, West Islip, NY
K. Hue-Roye
Laboratory of Immunochemistry, New York Blood Center, New York, NY
C. Lomas-Francis
Laboratory of Immunohematology, New York Blood Center, Long Island City, NY
Z. Hu
Laboratory of Immunohematology, New York Blood Center, Long Island City, NY
S. Vege
Molecular Blood Group and Platelet Testing Laboratory, American Red Cross, Philadelphia, PA
C.M. Westhoff
Molecular Blood Group and Platelet Testing Laboratory, American Red Cross, Philadelphia, PA
M.E. Reid
New York Blood Center, New York, NY
DOI: https://doi.org/10.21307/immunohematology-2019-291 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 160 - 164
Published on: Mar 25, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 A. Murdock, D. Assip, K. Hue-Roye, C. Lomas-Francis, Z. Hu, S. Vege, C.M. Westhoff, M.E. Reid, published by American National Red Cross
This work is licensed under the Creative Commons License.